Materials and Methods
Visual inspection and sequence removing was done with Jalview. Resulting multiple sequence alignment was used as profile for psi-blast (e-value=0.0001). Several rounds of psi-blast were done, removing redundant sequences (95%) until no new sequence was found. The same protocol was applied to perform C2HRNizp1 alignment. Sequence search was done using mouse C2HRNizp1 (residues V398 to K434).
Histone overlay assays
MODified TM Histone Peptide Arrays were purchased from Active Motif. They enable screening in a single experiment of 59 acetylation, methylation, phosphorylation and citrullination modifications on the entire Nterminal tails of histones H2A, H2B, H3 and H4. A series of synthetic 19mer histone H2A, H2B, H3 and H4 peptides, each of which may contain as many as four modifications, are spotted in duplicate onto a glass slide, generating a total of 384 unique histone modification combinations. Following overnight blocking at 4 °C with 5% milk in TTBS buffer (10 mM Tris/HCl pH 7.4, 150 mM NaCl, 0.05% Tween 20), the array was washed twice with TTBS and once with binding buffer (50 mM Tris/HCl pH 7.5, 300 mM NaCl, 0.1% NP-40, protease inhibitors). The array was then incubated, for 2-4 h at room temperature, with 1 μM solution of GST-tagged PHDv-C5HCHNSD1 in binding buffer. After three washes with binding buffer, the array was incubated with primary antibody anti-GST (1 : 1000) in 5% milk/TTBS for 1 h at room temperature. The array was then washed three times with TTBS and incubated for 1 h at room temperature with a secondary antibody HRP-conjugated (1 : 10000) in 5% milk/TTBS. Three washes with TTBS followed, and ECLTM Western Blotting detection solution (GE Healthcare) was added and incubated on the array surface for 5 min at room temperature. The image was captured by the ImageQuantTM ECL image analysis system (GE Healthcare). (1); Y2142N (1); H2143E (3); H2143Y (1); H2143Q (1); C2146R(1); R2152Q (2); C2159Y (1); H2162R (1) C5HCH C2164R (1); C2164Y (1); C2167R (3); C2178R (1); F2182I (1); C2183S (1);H2205R (1); C2178Y (1) 1. Tatton-Brown,K., Douglas,J., Coleman,K., Baujat,G., Cole,T.R., Das,S., Horn,D., Hughes,H.E., Temple,I.K., Faravelli,F., et al. (2005) 
PHDvC5HCHNSD1
Active residues D2119, F2122-C2124, H2143, L2147, W2157, E2158, M2177, E2204
Passive residues E2120, G2125, A2127, Q2129, V2131, K2134, K2135, D2145, N2148, P2153, G2155, K2156, E2176, R2199, T2203, D2206
C2HRNzip1
Active residues R415, W416, R417, V418, F420, R422
Passive residues K403, K412, N419, I421, L424, R425 Notably, residue R425Nizp1 has a very high R2 rate, it is located at the end of the α-helix and is most likely affected by fraying effects of the α-helix that reflect into conformational exchange and line broadening.
Conceivably, the conformational exchange observed for R425 is due to the absence of the fourth Zn 2+ binding residue in position 427, thus reducing by one helical turn the α-helix. 
Figure S4
A) 1 H-1D NMR spectra of C2HRNizp1 wild-type and mutants showing that all mutants are well folded. B)
Integral of the radial distribution function g(r) of the Sulfur (Sγ of C407 and C410), of the Nitrogen (Nε of H423) and of the water Oxygen (O) atoms around the Zn 2+ ion during the QM/MM analysis (100 ps). A maximum radius of 5 Å is showed in order to simplify the visualization of the result. The analysis reveals that within a radius of 2.2 Å Zn 2+ is stably tetra-coordinated by two Sγ atoms, by one Nε and one O atom. 
